openPR Logo
Press release

Pharma ADMET Testing Market Analysis, Leading Trends And Global Forecast 2023 To 2032 | Thermo Fisher Scientific Inc., Abbott Laboratories, The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc.

09-25-2023 09:32 AM CET | Health & Medicine

Press release from: The Business research company

Pharma ADMET Testing Market Share

Pharma ADMET Testing Market Share

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Pharma ADMET Testing Global Market Report 2023 identifies rising number of product approvals as the major driver for the Pharma ADMET Testing market's growth in the forecast period. Product approvals refer to the process by which regulatory authorities, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, grant permission for a product to be marketed and sold to the public. ADMET testing is beneficial for determining the safety and efficacy of novel products and is mandatory in product regulatory approvals

The global pharma ADMET testing market size is expected to grow from $7.71 billion in 2022 to $8.62 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of pharma ADMET testing market is expected to reach $13.1 billion in 2027 at a CAGR of 11.2%.

Download Free Sample Of Pharma ADMET Testing Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

Major competitors in the Pharma ADMET Testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Bio-Rad Laboratories Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., and Accelrys Inc.

A key trend in the Pharma ADMET Testing market includes product innovations. Major companies in the pharma ADMET testing market are introducing innovative products such as Logica to sustain their position in the market. For instance, in April 2022, Charles River Laboratories International Inc., a US-based pharmaceutical company, and Valo Health Inc., a US-based AI-health solution company, launched Logica, an AI-based drug development solution.

Read More On The Global Pharma ADMET Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

The Pharma ADMET Testing market is segmented -

By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Asia-Pacific was the largest region in the Pharma ADMET Testing market.

The Business Research Company's "Global Pharma ADMET Testing Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Pharma ADMET Testing Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12024

The Table Of Content For The Pharma ADMET Testing Market Include:
1. Executive Summary
2. Pharma ADMET Testing Market Characteristics
3. Pharma ADMET Testing Market Trends And Strategies
4. Pharma ADMET Testing Market - Macro Economic Scenario
5. Global Pharma ADMET Testing Historic Market Size and Growth, 2017 - 2022, Value ($ Billion
……
32. Global Pharma ADMET Testing Market Competitive Benchmarking
33. Global Pharma ADMET Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Pharma ADMET Testing Market
35. Pharma ADMET Testing Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharma ADMET Testing Market Analysis, Leading Trends And Global Forecast 2023 To 2032 | Thermo Fisher Scientific Inc., Abbott Laboratories, The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc. here

News-ID: 3221393 • Views:

More Releases from The Business research company

Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: Innovative Products Boosting Profitability in the Orthokeratology Lens Market
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Orthokeratology Lens Market Through 2025? The market for orthokeratology lenses has seen a significant increase in size over recent years. It's projected to expand from $2.56 billion in 2024 to $2.75 billion in 2025, with a compound annual growth rate (CAGR) of
Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 Billion Milestone
Ventricular Assist Device Industry Outlook 2025-2029: Market Set to Cross $3.87 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Ventricular Assist Device Market Size By 2025? The market size of the ventricular assist device has seen rapid expansion in recent years. A growth from $2.12 billion in 2024 to $2.37 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of 11.8%.
Key Trends Reshaping the Sunglasses Market: Leading Sunglass Brands Embrace AI With Chatgpt-Enabled Smart Eyewear Industry Transformation
Key Trends Reshaping the Sunglasses Market: Leading Sunglass Brands Embrace AI W …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sunglasses Market Size Growth Forecast: What to Expect by 2025? In recent times, the market size of sunglasses has been on a progressive rise. It is projected to increase from $18.11 billion in 2024 to an estimated $18.93 billion in 2025, experiencing a compound annual growth rate (CAGR) of
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Key Catalyst Accelerating PTA Balloon Catheter Market Growth in 2025
Advanced Diagnostics And Treatments Drive Demand For PTA Balloon Catheters: A Ke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. PTA Balloon Catheter Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the recent past, the market size for pta balloon catheter has seen substantial growth. The projections reveal that the growth scale will go up from $2.33 billion in 2024 to $2.56 billion in

All 5 Releases


More Releases for ADMET

Evolving Market Trends In The Pharma ADMET Testing Industry: The Impact Of Produ …
The Pharma ADMET Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Pharma ADMET Testing Market Size During the Forecast Period? The market scale for pharma ADMET testing has seen substantial expansion in the past few years. The market, which is projected
The Influence Of Increasing Product Approvals On The Pharma ADMET Testing Market …
What combination of drivers is leading to accelerated growth in the pharma admet testing market? The pharma ADMET testing market is being propelled by an increasing count of product authorizations. These authorizations are described as the procedures through which bodies like the U.S. Food and Drug Administration or the European Medicines Agency give the green light for a product to be commercialized and available for the general public. The use of
Pharma ADMET Testing Market Global Analysis & Forecast 2028
The Pharma ADMET Testing Market Research study to 2028 enhances the decision-making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at The Insight Partners. The Pharma ADMET Testing Industry analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Market Players Density: Understanding Its Impact on Business Dynamics The Pharma ADMET Testing Market market is
Pharma ADMET Testing Market to Reach US$ 13,578.62 Million by 2028
The pharma ADMET testing market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028. An exclusive Pharma ADMET Testing Market research report has been fabricated through the in depth analysis of the market dynamics across five regions including North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation
Wire Tension Tester Market | ABB, ADMET, Continental, GAP Group
The global wire tension tester market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the wire tension tester market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Pharma ADMET Testing Market Comprehensive Analysis and Future Estimations by 202 …
The Pharma ADMET Testing Market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028. The report highlights trends prevailing in the market and factors driving the market growth. The market growth is attributed to the high rate of late-stage drug failure and the increasing number of products approvals and launches.